tizanidine
- Product NDC
- 60760-253
- 11-digit product format
- 607600253
- Labeler code
- 60760
- Product ID
- 60760-253_d27f27fe-76fe-a220-e053-2995a90af29f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA076533
- Marketing category
- ANDA
- Marketing start
- 2004-01-16
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-253-04 | 60760025304 | 4 TABLET in 1 BOTTLE, PLASTIC (60760-253-04) | 4 tablet | 2018-03-05 | 0000-00-00 | No | No | Current |
| 60760-253-10 | 60760025310 | 10 TABLET in 1 BOTTLE, PLASTIC (60760-253-10) | 10 tablet | 2018-03-05 | 0000-00-00 | No | No | Current |
| 60760-253-15 | 60760025315 | 15 TABLET in 1 BOTTLE, PLASTIC (60760-253-15) | 15 tablet | 2017-11-17 | 0000-00-00 | No | No | Current |
| 60760-253-30 | 60760025330 | 30 TABLET in 1 BOTTLE, PLASTIC (60760-253-30) | 30 tablet | 2017-11-17 | 0000-00-00 | No | No | Current |
| 60760-253-90 | 60760025390 | 90 TABLET in 1 BOTTLE, PLASTIC (60760-253-90) | 90 tablet | 2017-11-17 | 0000-00-00 | No | No | Current |